Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-150 in Small Fiber Neuropathy Pain
NCT03304522Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Sep 2017
- Primary completion
- Oct 2018
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of VX-150 in small fiber neuropathy (SFN), sponsored by Vertex Pharmaceuticals. Started Sep 2017; status: completed.
02
Drugs
VX-150
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT03304522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03304522.